通过固定他的标签融合蛋白技术对抗伪过敏剂的MrgX2-向接体屏幕

Zhaomin Xia1, Qiumei Zhu2, Yi Shan1

  • 1School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.

PubMed
概括

开发了一种新的细胞膜染色学方法,用于选与Mas相关的G蛋白结合受体X2 (MrgX2) 抗体,识别具有显著反伪过敏活性的Z-3578化合物.